Cancer Research Insights & Advancements

Explore updates on our innovative clinical trials, advancements in cancer research, fundraising efforts and the latest developments in oncology.

For media inquiries: media@marycrowley.org

Sort By

THREE YEAR FOLLOW UP OF GMCSF/BI-SHRNA FURIN DNA TRANSFECTED AUTOLOGOUS TUMOR IMMUNOTHERAPY (VIGIL™) IN METASTATIC ADVANCED EWING’S SARCOMA

Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing’s Sarcoma. Molecular Therapy.

ABC DFW: IMMUNOTHERAPY BOOSTS BODY’S DEFENSE

Grandmother with cancer battles the odds with new immunotherapy clinical trial.

MARY CROWLEY QUARTERLY: VOLUME 6 ISSUE 2

MARY CROWLEY QUARTERLY: VOLUME 6 ISSUE 1

MARY CROWLEY QUARTERLY: VOLUME 5 ISSUE 4

HOCKEY FIGHTS CANCER 2015

Team partners with Dallas-area cancer-fighting organizations to raise funds for cancer research and support programs at the annual Hockey Fights Cancer event.

Pages: 12345678910111213141516171819202122232425262728293031323334

Connect With Us

Whether you want to give a spark of hope or you are looking for it, we are here to help. If you have any questions or concerns, please contact us here.

7777 Forest Lane,
Building C-707
Dallas, TX 75230

972.566.3000

For media inquiries: media@marycrowley.org

Cancer Research Insights & Advancements

Subscribe to Our Newsletter

Connect With Us